指南与共识肺栓塞与肺血管病

超声心动图轻度升高的肺动脉收缩压:弥合当前指南的空白

Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines.
指南 / 共识 · Lancet Respir Med · 2021-07-21

综述指出超声估测肺动脉收缩压>30 mm Hg在健康人群中属异常,超过40%的临床指征超声心动图报告此值,常伴代谢及心肺合并症,与5年死亡率25-40%相关,但现行指南未充分强调该人群的风险及降低风险策略。

要点

  • 超声估测肺动脉收缩压>30 mm Hg已超出多数健康人正常范围。
  • 该发现见于>40%临床指征超声心动图,常伴代谢及心肺合并症。
  • 肺动脉收缩压升高与5年死亡率25-40%相关,需多学科风险降低策略。

核心结论

  • 超声心动图轻度升高的肺动脉收缩压与死亡率增加相关,但现行指南未充分强调该人群的风险及风险降低方法。

研究设计与样本

  • 综述类文章,检索范围未在摘要中报告。

主要发现

  • 健康个体右心导管检查的平均肺动脉收缩压为17-25 mm Hg。
  • 超声估测肺动脉收缩压>30 mm Hg超出多数健康个体正常范围。
  • 肺动脉收缩压>30 mm Hg见于>40%的临床指征超声心动图。
  • 该情况常伴代谢和心肺合并症,与5年死亡率25-40%相关。

关键数值与推荐

  • 超声估测肺动脉收缩压>30 mm Hg视为超出多数健康个体正常范围。
  • 肺动脉收缩压>30 mm Hg与5年死亡率25-40%相关。

临床怎么用

  • 对超声心动图报告肺动脉收缩压>30 mm Hg的患者应提高风险意识。
  • 对伴代谢和心肺合并症且肺动脉压力升高的患者考虑多学科风险降低策略。

局限性

  • 原文未报告综述的检索范围及纳入研究的具体特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pulmonary hypertension is associated with increased morbidity and mortality, and growing evidence suggests that even mild elevations in pulmonary artery pressure estimated with echocardiography are linked to increased mortality. In healthy individuals who undergo right heart catheterisation, the average pulmonary artery systolic pressure ranges from 17 mm Hg to 25 mm Hg; on echocardiography, estimated pulmonary artery systolic pressure of more than 30 mm Hg is outside the normal range for most healthy individuals. Increased pulmonary artery systolic pressure (>30 mm Hg) is reported on more than 40% of clinically indicated echocardiograms, often in the presence of metabolic and cardiopulmonary comorbidities, and is associated with a 5-year mortality of 25-40%. However, current guidelines do not sufficiently highlight risk and risk-reduction approaches for the sizable patient population with elevated pulmonary artery pressure who do not have underlying severe pulmonary vascular disease such as pulmonary arterial hypertension. Increased awareness of this frequently reported high-risk echocardiographic finding, and multidisciplinary risk-reduction approaches for patients with metabolic and cardiopulmonary comorbidities and elevated pulmonary artery pressure, are urgently needed.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Jankowich M, Maron BA, Choudhary G, et al. Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines. Lancet Respir Med. 2021. PMID: 34270923. doi:10.1016/S2213-2600(21)00072-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。